MT
Marker Therapeutics Inc
🇺🇸XNAS.MRKRUnited StatesHealthcare
$1.15USDdown -0.04 (-3.36%)OpenDelayed5:03 PM
Price$1.15-0.04 (-3.36%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US57055L2060
- CUSIP
- 876033200
Company
- Employees
- 5
- Headquarters
- Houston, United States
- CEO
- Dr. Juan F. Vera M.D.
Market
- Shares outstanding
- 16.7M
- Market cap
- $19.17M
Highlights
- Market cap
- $19.34M
- EPS LTM
- -$0.52calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -2.20calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $2.34M-56.64%down year on year
- Net income
- -$8.71M+40.39%up year on year
- Gross margin
- -122.08%+37.25%up year on year
- Free cash flow
- -$9.76M+10.36%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.